US2020289038A1PendingUtilityA1
Analyte sensing biointerface
Est. expiryApr 15, 2025(expired)· nominal 20-yr term from priority
A61B 5/0031A61B 5/14532C12Q 1/001B33Y 80/00A61B 5/14865A61B 5/1486C12Q 1/006
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein is an analyte sensing biointerface that comprises a sensing electrode incorporated within a non-conductive matrix comprising a plurality of passageways extending through the matrix to the sensing electrode. Also disclosed herein are methods of manufacturing a sensing biointerface and methods of detecting an analyte within tissue of a host using an analyte sensing biointerface.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An implantable continuous glucose sensor system, comprising:
a working electrode configured to measure a signal indicative of a glucose concentration; a membrane disposed on the working electrode, wherein the membrane comprises a biointerface, wherein the biointerface comprises an electrically conductive material, wherein the biointerface is configured to promote a foreign body response that will not substantially attack or attempt to block sensing of glucose; and electronics electrically coupled to the working electrode.
2 . The sensor of claim 1 , wherein the biointerface comprises an enzyme.
3 . The sensor of claim 2 , wherein the biointerface further comprises a resistance domain disposed over the enzyme.
4 . The sensor of claim 1 , wherein the biointerface further comprises a bioactive agent.
5 . The sensor of claim 1 , wherein the biointerface is substantially planar.Join the waitlist — get patent alerts
Track US2020289038A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.